Food service companies set to invest in the international markets

In spite of the continuous challenges in the global economic environment there has been significant and sustained growth in the global food service industry which currently amounts to USD 2.55 trillion, with more than 65% spending coming from the emerging markets. According to food service industry reports, the market sector can be broadly categorized into the self-operated caterers and contract caterers in which the providers are responsible for supplying food and beverage services to their customers which includes a wide variety of end markets.

The contract catering service in the food service industry usually operates through an outsourcing structure facilitated by a firm or a specialized organization on a contractual basis. Since organizations are always searching for cost effective ways that self-administers food and supports services, the demand for the contract food service caterers is always high. The contract caterers have defined patents such as civil servants, workers, and patients who resort to canteen food and meals at affordable rates on a regular basis. Depending on factors like financial risks, potential compensations, profit and loss, the contracts can be divided into three types of contracts:

• Profit and loss
• Fixed price
• Fee based or cost plus

The food service market provides different kinds of benefits to their clients. To cite an instance, their delivery structures are flexible and consistent and the clients do not have to bother about the health and safety regulatory regime about the products.

The market segment can be further classified into five major end markets, namely,

• Healthcare and senior
• Business and industry
• Education
• Sports, leisure, and defense
• Offshore and remote.

Of the five segments, the business and industry market accounts for the maximum revenues but the industry experts suggest that the long-term growth opportunities lie in the healthcare and education sector.


Market outlook

The international markets are some of places that display the potential for maximum growth. In 2012, the food service sales were recorded at USD 2.6 trillion and are forecasted to grow further to reach USD 3.4 trillion by 2017. The food service sales are expected to grow most rapidly in Asia Pacific – growing by 39.1%, while Latin America follows close behind with an increase of 62.1%. However, North America is expected to face slow growth because of the conundrum of fierce competition in a saturated market.

For further insights,

Visit: http://www.researchonglobalmarkets.com/global-foodservice-market-2014-2018.html


About Research on Global Markets

Research on Global Markets is a leading source for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfill all your information-related requirements.


For more details on the content of each report and ordering information please contact:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com

Video:

Printing ink manufacturing industry set to grow to address the growing demand

The printing ink industry is greatly dependent on its consumers and its auxiliary applications. Research on printing ink industry states that the production value of the printing ink market will reach USD 18.2 billion by 2017, of which Asia- Pacific, mainly China will be the fastest growing region in the world ink market.

According to market reports, the market is growing at an exponential rate expected to reach a CAGR of 5.5% by 2017 with packaging and publishing printing becoming the largest segment of end users in the market. Furthermore, driving this incessant growth is the demand for environmentally friendly ink as well as technological innovations that are opening up new channels in UV and ink-jet ink.


Emerging markets in the printing ink industry

US has always remained the single largest regional market both in terms of volume as well as value sales while the growth of the European market is fuelled by sales of UV, free radical and cationic inks. Despite the robust development in these regions, the emerging trends in developing countries have triggered a growth of this market segment even in emerging economies. The opening up of economies like India and China has further ushered in the growth of the sector in these Asian markets. With brand owners seeking innovative packaging for their product, which will give them a competitive advantage - a large role in which is played by the printing ink, printing ink manufacturers are expecting that the market will reach US$18.2 billion by the year 2017. Joining in this bandwagon of printing ink manufacturers is the China’s folding carton-printing industries that are currently using water based inks to publish, thus resulting in further expansion of the markets.


Technological advancements revolutionizing the ink manufacturing sector

With printing presses using latest automated equipment, and economical friendly ink, the ink manufacturing sector has been revolutionized of late. Lithographic ink is the largest segment in the market, though the digital ink segment is predicted to record the fastest CAGR of 3.7%. Driving the growth in this sector is the improvement in the screen printing technology as well as the establishment of internal graphics that facilitate professional ink printing.

For further insights,

Visit: http://www.researchonglobalmarkets.com/global-database-of-printing-ink-producers-company-names-financial-performance-key-executives-and-contact-details.html


About Research on Global Markets

Research on Global Markets is a leading source for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfill all your information-related requirements.


For more details on the content of each report and ordering information please contact:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com

Video:

Growth of the migraine treatment market anticipated in lieu of recent drug discoveries

The new report suggests that the global migraine treatment market is coming out with two new pharmaceutical agents and pending drugs that will improve the market moderately over the coming years. The market is estimated to grow from USD 2.5 billion in 2012 to USD 3.7 billion by 2023, recording an annual compound growth rate of 3.6%.



United States remains dominant

As per the research on the migraine market, United States remains dominant with more than 77% market share and is expected to further increase its lead by 2023 reaching up to 84% of the total market. All the new drugs are developed to provide an alternative route of administration to the existing formulations for treating the acute problems involved with the disease. The drugs that contain the sumatriptan iontophoretic transdermal system like Teva, Zecurity and NuPathe and dihydroergotamine (Levadex, Allergan) AVP-825 (sumatriptan, OptiNose) and SUD-001 (sumatriptian oral spray, and SUDA) are being adopted by the medical fraternity as a means of naturopathic treatment. Besides this, there are other ditan and gepant drug classes which will soon be available in the market for the patients who don’t respond to the available acute migraine therapy.

All the recent developments in the migraine drug market are expected to spur the growth the market size since the developing therapies have the potential to steal the market shares from the existing drugs like triptans and ergot alkaloids. The developments are awaited with much anticipation because Botox remains the sole prophylactic treatment for chronic migraine for the foreseeable future.

For further insights,

Visit: http://www.researchonglobalmarkets.com/migraine-pipeline-review-h1-2014.html


About Research on Global Markets

Research on Global Markets is a leading source for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfill all your information-related requirements.


For more details on the content of each report and ordering information please contact:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


Video:

Types of brain tumor and their treatment

Healthcare reports on brain tumors state that brain tumor arises due to an abnormal development or growth of cells that have multiplied in an uncontrolled manner, rooting from the brain cells. The tumors are classified based on how aggressive they are – wherein lower-grade tumors often are benign while higher-grade tumors are malignant in nature.

When cells grow old or get damaged, they either undergo a programmed cell death (apoptosis) or get repaired naturally within the human body. However, during this process, mutations and alterations can occur in the cellular DNA that disrupt these regulatory processes and consequently cells that would have normally died, go on to survive and proliferate. These cells multiply and give rise to more cells, all of which contain the abnormal DNA. Eventually, these accumulating cells form a mass called a growth or tumor.


Types of brain tumor

Brain tumors are considered highly dangerous and may be primary tumors, in which case they originate in the brain, or secondary tumors that have spread to the brain from cancerous cells elsewhere in the body. Low grade tumors (grade 1 or 2) are usually slow growing multitudes that are not likely to spread. These tumors are classed as benign and are not considered a major threat, since they usually stay confined to the site of origin and do not invade other parts of the body.

Unlike benign tumors, malignant brain cancers have a high probability to spread to other tissues. Since malignant tumors usually are secondary tumors that have formed as a result of the spreading of cancerous cells they tend to be high-grade (grade 3 or 4), destructive cancers that grow quickly. These tumors require urgent treatment in order to protect the brain as well as the spinal cord.


Treatment

The treatment procedure for a brain tumor depends on its size and location. Although benign tumors do not tend to spread, they can cause considerable damage by creating pressure on other areas of the brain if they are not treated in the early stages. Grade 1 tumors can often be removed in a surgical procedure, however, grade 2 tumors often grow back and have the potential to mutate and turn into high-grade tumors.

A primary malignant tumor requires urgent treatment to prevent it from spreading and causing damage to other parts of the brain and body. Treatment may involve surgery, radiation, therapy and chemotherapy. However, since these tumors often grow back once they have been surgically removed, for patients with secondary brain tumors due to metastasized cancer, treatment is aimed at relieving symptoms, protracting survival and improving quality of life.

For further insights on therapeutic development for brain tumor alongwith comparative analysis at various stages and other details,
Visit: http://www.researchonglobalmarkets.com/brain-tumor-pipeline-review-h1-2014.html


About Research on Global Markets

Research on Global Markets is a leading source for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfill all your information-related requirements.


For more details on the content of each report and ordering information please contact:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


Video:

The drug market for Parkinson’s disease forecasted for slow growth

Parkinson’s disease is a disability of the brain that is characterized with the loss of balance, slowness of movement, alongwith shaking and stiffness in the later stages. This condition usually develops after the age of 50 and is one of the most common nervous system disorders that the elderly suffer from.

Incessant research on the treatment of Parkinson’s disease resulted in the introduction of the carbidopa or levodopa (Sinemet®) that had initially revolutionized the treatment of the Parkinson’s disease, after which 15 more drugs were introduced which treated the genetic condition by adjusting the level of dopamine in the brain by stimulating the unresponsive receptors of the brain. These drugs have improved medical care for the patients suffering from this degenerative disorder and have allowed the doctors to customize treatment solutions that maximize benefits and reduce the adverse reactions. With major drugs like Azilect, Stalevo and Comtan that are employed to treat this disease, losing their patents by 2019, the approval and introduction of late-stage pipeline drugs is expected to see a substantial increase. Inspite of this speculated increase, the market impact of emerging therapies will be severely affected by generic competition.


The three emerging therapies

As per the Parkinson’s research news, all the emerging therapies will have a moderate impact on the market growth. The industry analysts do not expect any kind of major shifts in the treatment paradigm of Parkinson’s disease in the coming decade. Furthermore, generic competition will further suppress the market growth and this means that the future therapies will need to clearly demonstrate superiority over the present therapies to gain a competitive edge in this mature market.


Unmet needs in the therapies

Despite these challenges, there is an urgent need of disease modifying treatment solutions for Parkinson’s disease treatment methods. The currently available late stage PD therapy concentrates on the symptomatic agents that targets only niche populations and these products are restricted by its commercial potential. One of the greatest needs in the treatment of this disease today, is agents that will delay its progression – something that is still far from realization.


Market outlook

In the coming years, the generalization of Parkinson’s disease drugs will create a fragmented market with no clear market leader as such. Healthcare analysts expect that there will be a large number of similarly priced drugs that will be competing for the same market share. Thus to gain a competitive advantage in this pharmaceutical market segment, future therapies need to differentiate themselves from other treatment options and establish market supremacy.


For further insights,

Visit: Parkinson's Disease - Pipeline Review, H1 2014


About Research on Global Markets

Research on Global Markets is a leading source for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfill all your information-related requirements.


For more details on the content of each report and ordering information please contact:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


Related Video

Improved understanding of colon cancer spurs development of molecular drugs

According to healthcare research reports on colorectal cancer it is one of the most fatal forms of cancer that accounts for the maximum number of cancer related deaths in the world. Even with sufficient advances in the molecular understanding of the disease, the colorectal cancer drug market is constantly vying to develop complex compounds with specific molecular targets that are required to treat the disease by addressing the complex pathways of the cancerous cells. However, most of these selective drugs are presently in preclinical and early clinical stages.

With an improved understanding of colorectal cancer, its widespread growth and spread has enabled the colon cancer market to develop strategies that lead to improved cures for patients. Furthermore, better understanding of the genetic alterations that contribute to the occurrence of colorectal cancer development and spread, have further led to the manufacturing of drugs that obstruct the growth of the tumor.

Currently, more than 300 companies are manufacturing more than 400 different drugs that target colorectal cancer. Moreover, according to colon cancer research, there are another 200 drugs that have been either ceased or suspended. Only until a decade ago, did Leucovorin form the mainstream drug to treat the cancer while Eloxatin established itself as the main component of therapy. The advent of the molecular targeted agents like the Avastin and Erbitux welcomed a new era in disease management wherein the survival levels improved greatly.

With the new molecularly targeted drugs, colon cancer research suggests that the survival rate has increased significantly. The drugs like bevacizumab are able to target the inherent abnormal pathways in the cancer cells and are much less toxic than the traditional selective chemotherapeutics.

Furthermore, with the US Food and Drug approving the molecular drugs for the treatment of mCRC in the clinic, the survival rates have greatly improved and progression rate of the cancerous cells have progressively decreased. This means that a host of new opportunities have opened up for the treatment of this particular cancerous condition and other related malignancies, which in turn has further spurred the development of the selective targeting drug development market.


For further insights,

Visit: Colon Cancer - Pipeline Review, H1 2014


About Research on Global Markets

Research on Global Markets is a leading source for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfill all your information-related requirements.


For more details on the content of each report and ordering information please contact:

Email: customerservice@researchonglobalmarkets.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonglobalmarkets.com
Blog: blog.researchonglobalmarkets.com


Related Video:

The Future of Retailing in South Korea to 2017

Synopsis

* Future forecasts and historic market data can improve market and strategic planning.
* Understand which channels and products will be the major winners and losers in the coming years.
* Know the share of sales between different products in your key channels and how this will develop.
* Assess the impact of economic recession and recovery on market growth.


Summary

* Why was the report written?
- "The Future of Retailing in South Korea to 2017" is based upon an extensive, cross-country, industry research program which brings together Canadeans research, modelling, and analysis expertise in order to develop uniquely detailed market data. It provides detailed quantitative analysis of past and future trends - crucially providing retail sales data not just by channel and by product, but showing product sales through different channels. This allows marketers interested in retailing to determine how to account for the development of retail trade overall and to know which channels are showing growth for which products in the coming years. It aims to capture the shift to new channels depending on the country, the effects of recession, and shifting consumer behavior; thereby providing timely, highly comparable analysis of the retail markets. Data sets are provided for 2007 through to 2017, with actuals being provided for 2012. All initial market sizing and analysis is conducted in local currency in order to ensure local trends are reflected in the data before conversion into other currencies.

* What is the current market landscape and what is changing?
- South Korean retail sales grew at a CAGR of 4.35% during 2007-2012 and expected to grow with a CAGR of over 4.68% during the forecast period.

* What are the key drivers behind recent market changes?
- Consumers have been reacting to the effects of the global recession and the following recovery period on their discretionary spending - retail markets have been no exception. While the country by country market changes have varied, nowhere has been left totally untouched. This report quantitatively examines the components of change in the market by looking at historic and future growth patterns - how changes in consumers behavior have affected the retail sector for different product categories and channels.

* What makes this report unique and essential to read?
- This report provides detailed data on the size and development of retail sales of individual product types through specific retail channels and formats in South Korea. It provides a detailed and comprehensive quantitative analysis of the trends affecting market development through both historic and forecast data.


Scope

Detailed category coverage is provided, covering 25 products, across eight product groups that include: Apparel, Accessories and Luxury Goods, Book, News and Stationery, Electricals and Electronics, Food and Grocery, Furniture and Floor Coverings, Home and Garden Products, Music, Video and Entertainment Software, and Sports and Leisure Equipment.
Detailed channel coverage is provided, covering 17 products, across four channel groups that include: General Retailers, Specialist Retailers, Value Retailers, and Online Retailers.
Forecasts allow marketers to understand the future pattern of market trends, from winners and losers to category and channel dynamics, and therefore quickly and easily identify the key areas in which they want to compete in the future.


Reasons to Buy

According to the Strategy and Finance ministry of South Korea, the countrys economic growth in 2013 is forecast at 3%, lower than the 3.6% projected by the IMF, and 3.2% by the Bank of Korea.


Key Highlights

General retailers was the largest channel group with hypermarkets, supermarkets and hard-discounters recording the highest sales among the various channels under the general retailers channel group. The convenience stores (including independents) and gas stations channel recorded the second highest sales.

Consumers growing preference for private label brands threatens national brands. As of May 2012, private-label products represent more than 25% of the total retail sales of Koreas three major discount chains: E-Mart, Home plus, and Lotte Mart.

In 2012, more than three quarters of the South Korean population between the ages of 10 and 40 years used the internet, symbolizing high internet user penetrations.


To order this report:

Email: support@researchonsouthkorea.com
US:  +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE:  Researchonsouthkorea.com


RELATED LINK:

The Future of Retailing in South Korea to 2017


RELATED VIDEO: